Validation of the Functional Assessment of Chronic Illness Therapy-Fatigue Scale in Patients with Moderately to Severely Active Systemic Lupus Erythematosus, Participating in a Clinical Trial
Open Access
- 15 January 2011
- journal article
- Published by The Journal of Rheumatology in The Journal of Rheumatology
- Vol. 38 (4), 672-679
- https://doi.org/10.3899/jrheum.100799
Abstract
Objective. Fatigue is a common symptom of systemic lupus erythematosus (SLE). Our objective was to validate the 13-item Functional Assessment of Chronic Illness Therapy (FACIT)-Fatigue scale in patients with SLE. Methods. The FACIT-Fatigue, Medical Outcomes Study Short-Form-36 (SF-36) questionnaire, Brief Pain Inventory (BPI), and Patient Global Assessment Visual Analog Scale (Patient-GA) were completed at baseline and at Weeks 12, 24, and 52 by patients with moderately to severely active extrarenal SLE. The patients were participating in a rituximab clinical trial. The British Isles Lupus Assessment Group (BILAG) disease activity index and the Physician Global Assessment Visual Analog Scale (Physician-GA) were completed by physicians at the same visits. Results. At baseline, 254 patients completed the FACIT-Fatigue scale. Cronbach’s α was > 0.95 at all visits. In cross-sectional analyses, FACIT-Fatigue scores differentiated between groups defined by BILAG General domain ratings. FACIT-Fatigue had moderate-high correlations (r = 0.5–0.8) with SF-36, BPI, and Patient-GA, but poor correlations with BILAG total score and Physician-GA (r = 0.1–0.3). At Weeks 12, 24, and 52, mean FACIT-Fatigue scale improvement was higher in patients who improved versus those who remained unchanged on the BILAG General domain. FACIT-Fatigue scale scores remained stable for patients with worsened BILAG General domain ratings compared to baseline. Distribution and anchor-based estimates suggested a minimally important difference (MID) range of 3–6 points. Conclusion. The FACIT-Fatigue scale is a valid and responsive measure of fatigue in patients with SLE. MID in this SLE sample is similar to that derived previously in other populations. Since few patients experienced worsening BILAG General and Musculoskeletal domains in this study, further research is warranted to evaluate the responsiveness of FACIT-Fatigue to worsening of these domains.This publication has 23 references indexed in Scilit:
- Understanding the Epidemiology and Progression of Systemic Lupus ErythematosusSeminars in Arthritis and Rheumatism, 2010
- Fatigue and Sleep Disturbance in Adult Survivors of Childhood Cancer: A Report from the Childhood Cancer Survivor Study (CCSS)Sleep, 2008
- The relationship between cancer and medication exposures in systemic lupus erythaematosus: a case-cohort studyAnnals Of The Rheumatic Diseases, 2008
- Functional Assessment of Chronic Illness Therapy-Fatigue Scale is valid in patients with psoriatic arthritisAnnals Of The Rheumatic Diseases, 2007
- Systemic lupus erythematosus in a multiethnic US cohort LUMINA (XLI): factors predictive of self-reported work disabilityAnnals Of The Rheumatic Diseases, 2006
- A comparison between long-term survivors of Hodgkin's disease and their siblings on fatigue level and factors predicting for increased fatigueAnnals of Oncology, 2005
- Reductions in Anaemia and Fatigue are Associated with Improvements in Productivity in Cancer Patients Receiving ChemotherapyPharmacoEconomics, 2005
- Epoetin Alfa Therapy Increases Hemoglobin Levels and Improves Quality of Life in Patients With Cancer-Related Anemia Who Are Not Receiving Chemotherapy and Patients With Anemia Who Are Receiving ChemotherapyJournal of Clinical Oncology, 2001
- The prevalence and associations of fatigue in systemic lupus erythematosusRheumatology, 2000
- Measuring fatigue and other anemia-related symptoms with the Functional Assessment of Cancer Therapy (FACT) measurement systemJournal of Pain and Symptom Management, 1997